Research Article

Rosin Derivative IDOAMP Inhibits Prostate Cancer Growth via Activating RIPK1/RIPK3/MLKL Signaling Pathway

Figure 6

The mechanism of IDOAMP-induced inhibition of prostate cancer cell growth.